Chapter 20 - Immune-mediated disorders

https://doi.org/10.1016/B978-0-12-802395-2.00020-1Get rights and content

Abstract

Paraneoplastic and autoimmune encephalitis comprise a group of immune-mediated disorders that are associated with different immune effector mechanisms. Classic paraneoplastic neurologic syndromes are triggered by an antitumor immune response. The disease is considered to result from a T-cell response; in addition, patients harbour high titers of autoantibodies against intracellular antigens that are considered as epiphenomenon but are useful diagnostic markers. Neuropathology consists of T-cell-dominated inflammation, marked neuronal loss, and microglial activation with upregulation of HLA-DR. In the last decade, an increasing number of diseases associated with autoantibodies against neuronal surface antigens have been described. There is strong evidence that these autoantibodies are pathogenic and the associated syndromes are generally termed as antineuronal autoimmune encephalitis. Patients typically present with limbic, multifocal, or diffuse encephalitis and respond to immunotherapy. Neuropathologic descriptions are restricted to few biopsy and autopsy specimens and show mild inflammatory infiltrates and microglial activation, together with reduced expression of the respective target antigens, immunoglobulin deposits, and a variable degree of complement activation. Other putative autoimmune disorders of the central nervous system include, among others, Rasmussen encephalitis, chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS), acute cerebellitis, Susac syndrome, and Hashimoto encephalitis. While pathologic studies suggest an immune-mediated disease for Rasmussen encephalitis, CLIPPERS, acute cerebellitis, and Susac syndrome, neuropathologic descriptions of Hashimoto encephalitis are rare and the pathogenesis deserves further study.

Section snippets

Acute cerebellitis

Acute cerebellitis is a rare pancerebellar syndrome that typically occurs in children. Most common presenting symptoms are headache, vomiting, dysmetria, and truncal ataxia (De Bruecker et al., 2004, Desai and Mitchell, 2012). Severe cases of cerebellitis may be fulminant and deaths resulting from marked cerebellar swelling and herniation have been reported. The disease is believed to be an infectious, postinfectious, or postvaccination disorder and has been variously attributed to

References (99)

  • M.J. Titulaer et al.

    Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. The Lancet

    Neurology

    (2013)
  • S.L. Tsai et al.

    Central nervous system vasculitis with positive antithyroid antibodies in an adolescent boy

    Pediatr Neurol

    (2011)
  • M. Veciana et al.

    EEG extreme delta brush: an ictal pattern in patients with anti-NMDA receptor encephalitis

    Epilepsy Behav

    (2015)
  • M. Wirenfeldt et al.

    Increased activation of Iba1 + microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex

    Neurobiol Dis

    (2009)
  • F. Aboul-Enein et al.

    Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome

    Neuropathol Appl Neurobiol

    (2008)
  • N. Amador et al.

    Acute cerebellitis presenting as tumor. Report of two cases

    J Neurosurg

    (2007)
  • B.M. Ances et al.

    Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates

    Brain

    (2005)
  • H. Arino et al.

    Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies

    JAMA Neurol

    (2015)
  • H. Arino et al.

    Anti-LGI1-associated cognitive impairment: presentation and long-term outcome

    Neurology

    (2016)
  • T. Armangue et al.

    Pediatric anti-N-methyl-D-aspartate receptor encephalitis – clinical analysis and novel findings in a series of 20 patients

    Journal of Pediatrics

    (2013)
  • T. Armangue et al.

    Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies

    JAMA Neurol

    (2016)
  • B. Balint et al.

    Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies

    Neurology

    (2014)
  • M. Barnett et al.

    Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody

    J Neurol Neurosurg Psychiatry

    (2001)
  • L. Bataller et al.

    Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus

    Brain

    (2001)
  • L. Bataller et al.

    Autoantigen diversity in the opsoclonus-myoclonus syndrome

    Ann Neurol

    (2003)
  • E.R. Bickerstaff

    Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis

    Br Med J

    (1957)
  • C.G. Bien et al.

    The natural history of Rasmussen's encephalitis

    Brain

    (2002)
  • C.G. Bien et al.

    Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis

    Brain

    (2012)
  • A. Boronat et al.

    Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels

    Ann Neurol

    (2013)
  • L. Brain et al.

    Hashimoto's disease and encephalopathy

    Lancet

    (1966)
  • S. Busse et al.

    Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients

    Eur Arch Psychiatry Clin Neurosci

    (2014)
  • L. Dahm et al.

    Seroprevalence of autoantibodies against brain antigens in health and disease

    Ann Neurol

    (2014)
  • R.C. Dale et al.

    Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders

    Brain

    (2012)
  • J. Dalmau et al.

    Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders

    Brain

    (1999)
  • J. Dalmau et al.

    Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

    Ann Neurol

    (2007)
  • Y. De Bruecker et al.

    MRI findings in acute cerebellitis

    Eur Radiol

    (2004)
  • E. de Graaff et al.

    Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration

    Ann Neurol

    (2012)
  • H.J. De Graaff et al.

    Fatal B-cell lymphoma following chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids

    JAMA Neurol

    (2013)
  • D. Denny-Brown

    Primary sensory neuropathy with muscular changes associated with carcinoma

    J Neurol Neurosurg Psychiatry

    (1948)
  • J. Desai et al.

    Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome

    J Child Neurol

    (2012)
  • J. Dorr et al.

    Characteristics of Susac syndrome: a review of all reported cases

    Nat Rev Neurol

    (2013)
  • C.M. Forchetti et al.

    Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism

    Neurology

    (1997)
  • E. Gelpi et al.

    Neuropathological criteria of anti-IgLON5-related tauopathy

    Acta Neuropathol

    (2016)
  • F. Ghawche et al.

    Hashimoto's encephalopathy: toxic or autoimmune mechanism?

    Rev Neurol

    (1992)
  • B. Giometto et al.

    Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers

    Arch Neurol

    (2010)
  • F. Graus et al.

    Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients

    Brain

    (2001)
  • F. Graus et al.

    Recommended diagnostic criteria for paraneoplastic neurological syndromes

    J Neurol Neurosurg Psychiatry

    (2004)
  • M. Greene et al.

    Antibodies to delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma

    JAMA Neurol

    (2014)
  • C. Hammer et al.

    Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity

    Mol Psychiatry

    (2014)

    • Cited by (21)

    • Brain on fire: an imaging-based review of autoimmune encephalitis

      2022, Clinical Imaging
      Citation Excerpt :

      Removal of the antibody typically results in recovery of receptor location or function; therefore, autoimmune encephalitis with cell surface antigens has a significantly better prognosis. Up to 80% of patients show significant improvement after therapy, albeit often with a prolonged recovery course.2,3,6,10 Association with malignancy in this group is variable, and a wider age range of patients, including children and young adults, may be affected.

    • Paraneoplastic and autoimmune encephalitis: Alterations of mood and emotion

      2021, Handbook of Clinical Neurology
      Citation Excerpt :

      There are many other antibodies that are directed against receptors and cell surface antigens, including glycine receptors, GABAA receptors, metabotropic glutamate5 receptors, dopamine D2 receptors, and dipeptidyl peptidase-like-6. Although they may also be associated with some neuropsychiatric symptoms (Dalmau et al., 2017; Hara et al., 2017; Höftberger and Lassmann, 2017; Oldham, 2017), their presence is generally associated with marked elemental neurological deficits or alterations in level of consciousness that result in patients rapidly undergoing neurological assessment (Bost et al., 2016). The paraneoplastic antibodies anti-Hu and anti-Ma2, respectively, associated with small cell lung carcinoma and testicular seminoma target intracellular antigens and mediate cell death via activation of T-cell immunological responses (Bernal et al., 2002; Bien et al., 2012; Lancaster and Dalmau, 2012).

    • Paraneoplastic neurological syndromes

      2019, Seminars in Diagnostic Pathology
      Citation Excerpt :

      Typically, the onset of the neurological disorder precedes the detection of the underlying malignancy, and the correct recognition of a PNS may be critical for the early diagnosis of cancer. Although PNS can occur with any type of tumours, the most frequently associated malignancies include small-cell lung cancer (SCLC), ovarian and breast cancer, neuroendocrine tumours, thymoma and lymphoma.1 This review focuses on the immunopathogenesis of PNS, along with their most relevant clinical findings, taking into account the latest advancements in the field.

    • Targeting Underlying Inflammation in Carcinoma Is Essential for the Resolution of Depressiveness

      2023, Cells

    • Multiple sclerosis: 2023 update

      2023, Free Neuropathology

    • Acute Cerebellar Inflammation and Related Ataxia: Mechanisms and Pathophysiology

      2022, Brain Sciences
    View all citing articles on Scopus
    View full text
    Copyright © 2018 Elsevier B.V. All rights reserved.